Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2011

Open Access 01-12-2011 | Original investigation

A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels

Authors: Sven Schinner, Reiner Füth, Kerstin Kempf, Stephan Martin, Holger S Willenberg, Matthias Schott, Wilfried Dinh, Werner A Scherbaum, Mark Lankisch

Published in: Cardiovascular Diabetology | Issue 1/2011

Login to get access

Abstract

Objective

Diabetes mellitus type 2 (DM2) is a risk factor for coronary heart disease (CHD). While there is a clear correlation of fasting blood glucose (FBG) and 2 h post-challenge blood glucose values (2h-BG) with microvascular complications, the risk for CHD conferred by glucose dysregulation antecedent to DM2 is less clear. Therefore, we investigated associations of FBG and 2h-BG values with the prevalence of CHD assessed by coronary angiography as the most sensitive diagnostic tool.

Research Design and Methods

Coronary angiography was performed in 1394 patients without known DM. Capillary blood glucose was analyzed before and 2 h after an oral glucose tolerance test. Associations between FBG as well as 2h-BG levels and the risk for CHD were assessed by logistic regression analysis.

Results

1064 (75%) of patients were diagnosed with CHD. 204 (15%) were diagnosed with so far unknown DM2, 274 (20%) with isolated impaired fasting glucose (IFG), 188 (13%) with isolated impaired glucose tolerance (IGT) and 282 (20%) with both, IGT and IFG. We found a continuous increase in the risk for CHD with fasting and post-challenge blood glucose values even in the subdiabetic range. This correlation did however not suggest clear cut-off values. The increase in risk for CHD reached statistical significance at FBG levels of > 120 mg/dl (Odds Ratio of 2.7 [1.3-5.6] and 2h-BG levels > 140 mg/dl (141-160 mg/dl OR 1.8 [1.1-2.9], which was however lost after adjusting for age, sex and BMI.

Conclusions

In our study population we found a continuous increased risk for CHD at fasting and 2h-BG levels in the sub-diabetic glucose range, but no clear cut-off values for cardiovascular risk.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kannel WB, McGee DL: Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979, 241 (19): 2035-8. 10.1001/jama.241.19.2035.CrossRefPubMed Kannel WB, McGee DL: Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979, 241 (19): 2035-8. 10.1001/jama.241.19.2035.CrossRefPubMed
2.
go back to reference Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993, 16 (2): 434-44. 10.2337/diacare.16.2.434.CrossRefPubMed Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993, 16 (2): 434-44. 10.2337/diacare.16.2.434.CrossRefPubMed
3.
go back to reference Sorkin JD, Muller DC, Fleg JL, Andres R: The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care. 2005, 28 (11): 2626-32. 10.2337/diacare.28.11.2626.CrossRefPubMed Sorkin JD, Muller DC, Fleg JL, Andres R: The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care. 2005, 28 (11): 2626-32. 10.2337/diacare.28.11.2626.CrossRefPubMed
4.
go back to reference Barrett-Connor E, Wingard DL, Criqui MH, Suarez L: Is borderline fasting hyperglycemia a risk factor for cardiovascular death?. J Chronic Dis. 1984, 37 (9-10): 773-9. 10.1016/0021-9681(84)90046-8.CrossRefPubMed Barrett-Connor E, Wingard DL, Criqui MH, Suarez L: Is borderline fasting hyperglycemia a risk factor for cardiovascular death?. J Chronic Dis. 1984, 37 (9-10): 773-9. 10.1016/0021-9681(84)90046-8.CrossRefPubMed
5.
go back to reference Henry P, Thomas F, Benetos A, Guize L: Impaired fasting glucose, blood pressure and cardiovascular disease mortality. Hypertension. 2002, 40 (4): 458-63. 10.1161/01.HYP.0000032853.95690.26.CrossRefPubMed Henry P, Thomas F, Benetos A, Guize L: Impaired fasting glucose, blood pressure and cardiovascular disease mortality. Hypertension. 2002, 40 (4): 458-63. 10.1161/01.HYP.0000032853.95690.26.CrossRefPubMed
6.
go back to reference Rodriguez BL, Abbott RD, Fujimoto W, Waitzfelder B, Chen R, Masaki K, Schatz I, Petrovitch H, Ross W, Yano K, Blanchette PL, Curb JD: The American Diabetes Association and World Health Organization classifications for diabetes: their impact on diabetes prevalence and total and cardiovascular disease mortality in elderly Japanese-American men. Diabetes Care. 2002, 25 (6): 951-5. 10.2337/diacare.25.6.951.CrossRefPubMed Rodriguez BL, Abbott RD, Fujimoto W, Waitzfelder B, Chen R, Masaki K, Schatz I, Petrovitch H, Ross W, Yano K, Blanchette PL, Curb JD: The American Diabetes Association and World Health Organization classifications for diabetes: their impact on diabetes prevalence and total and cardiovascular disease mortality in elderly Japanese-American men. Diabetes Care. 2002, 25 (6): 951-5. 10.2337/diacare.25.6.951.CrossRefPubMed
7.
go back to reference Wei M, Gibbons LW, Mitchell TL, Kampert JB, Stern MP, Blair SN: Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. Circulation. 2000, 101 (17): 2047-52.CrossRefPubMed Wei M, Gibbons LW, Mitchell TL, Kampert JB, Stern MP, Blair SN: Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. Circulation. 2000, 101 (17): 2047-52.CrossRefPubMed
8.
go back to reference Balkau B, Shipley M, Jarrett RJ, Pyörälä K, Pyörälä M, Forhan A, Eschwège E: High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care. 1998, 21 (3): 360-7. 10.2337/diacare.21.3.360.CrossRefPubMed Balkau B, Shipley M, Jarrett RJ, Pyörälä K, Pyörälä M, Forhan A, Eschwège E: High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care. 1998, 21 (3): 360-7. 10.2337/diacare.21.3.360.CrossRefPubMed
9.
go back to reference Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001, 161 (3): 397-405. 10.1001/archinte.161.3.397. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001, 161 (3): 397-405. 10.1001/archinte.161.3.397.
10.
go back to reference de Vegt F, Dekker JM, Ruhé HG, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ: Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia. 1999, 42 (8): 926-31. 10.1007/s001250051249.CrossRefPubMed de Vegt F, Dekker JM, Ruhé HG, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ: Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia. 1999, 42 (8): 926-31. 10.1007/s001250051249.CrossRefPubMed
11.
go back to reference Simons LA, Friedlander Y, McCallum J, Simons J: Fasting plasma glucose in non-diabetic elderly women predicts increased all-causes mortality and coronary heart disease risk. Aust N Z J Med. 2000, 30 (1): 41-7.CrossRefPubMed Simons LA, Friedlander Y, McCallum J, Simons J: Fasting plasma glucose in non-diabetic elderly women predicts increased all-causes mortality and coronary heart disease risk. Aust N Z J Med. 2000, 30 (1): 41-7.CrossRefPubMed
12.
go back to reference Pankow JS, Kwan DK, Duncan BB, Schmidt MI, Couper DJ, Golden S, Ballantyne CM: Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2007, 30 (2): 325-31. 10.2337/dc06-1457.CrossRefPubMed Pankow JS, Kwan DK, Duncan BB, Schmidt MI, Couper DJ, Golden S, Ballantyne CM: Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2007, 30 (2): 325-31. 10.2337/dc06-1457.CrossRefPubMed
13.
go back to reference Coutinho M, Gerstein HC, Wang Y, Yusuf S: The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999, 22 (2): 233-40. 10.2337/diacare.22.2.233.CrossRefPubMed Coutinho M, Gerstein HC, Wang Y, Yusuf S: The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999, 22 (2): 233-40. 10.2337/diacare.22.2.233.CrossRefPubMed
14.
go back to reference Lankisch M, Füth R, Schotes D, Rose B, Lapp H, Rathmann W, Haastert B, Gülker H, Scherbaum WA, Martin S: High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiography. Clin Res Cardiol. 2006, 95 (2): 80-7. 10.1007/s00392-006-0328-4.CrossRefPubMed Lankisch M, Füth R, Schotes D, Rose B, Lapp H, Rathmann W, Haastert B, Gülker H, Scherbaum WA, Martin S: High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiography. Clin Res Cardiol. 2006, 95 (2): 80-7. 10.1007/s00392-006-0328-4.CrossRefPubMed
15.
go back to reference Saely CH, Drexel H, Sourij H, Aczel S, Jahnel H, Zweiker R, Langer P, Marte T, Hoefle G, Benzer W, Wascher TC: Key role of postchallenge hyperglycemia for the presence and extent of coronary atherosclerosis: an angiographic study. Atherosclerosis. 2008, 199 (2): 317-22. 10.1016/j.atherosclerosis.2007.11.020.CrossRefPubMed Saely CH, Drexel H, Sourij H, Aczel S, Jahnel H, Zweiker R, Langer P, Marte T, Hoefle G, Benzer W, Wascher TC: Key role of postchallenge hyperglycemia for the presence and extent of coronary atherosclerosis: an angiographic study. Atherosclerosis. 2008, 199 (2): 317-22. 10.1016/j.atherosclerosis.2007.11.020.CrossRefPubMed
16.
go back to reference Hadaegh F, Fahimfar N, Khalili D, Sheikholeslami F, Azizi F: New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a Middle East population. Cardiovasc Diabetol. 2010, 9: 84-10.1186/1475-2840-9-84.PubMedCentralCrossRefPubMed Hadaegh F, Fahimfar N, Khalili D, Sheikholeslami F, Azizi F: New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a Middle East population. Cardiovasc Diabetol. 2010, 9: 84-10.1186/1475-2840-9-84.PubMedCentralCrossRefPubMed
17.
go back to reference Einarson TR, Hunchuck J, Hemels M: Relationship between blood glucose and carotid intima media thickness: A meta-analysis. Cardiovasc Diabetol. 2010, 9: 37-10.1186/1475-2840-9-37.PubMedCentralCrossRefPubMed Einarson TR, Hunchuck J, Hemels M: Relationship between blood glucose and carotid intima media thickness: A meta-analysis. Cardiovasc Diabetol. 2010, 9: 37-10.1186/1475-2840-9-37.PubMedCentralCrossRefPubMed
18.
go back to reference Pereg D, Elis A, Neuman Y, Mosseri M, Lishner M, Hermoni D: Cardiovascular risk in patients with fasting blood glucose levels within normal range. Am J Cardiol. 2010, 106 (11): 1602-5. 10.1016/j.amjcard.2010.07.036.CrossRefPubMed Pereg D, Elis A, Neuman Y, Mosseri M, Lishner M, Hermoni D: Cardiovascular risk in patients with fasting blood glucose levels within normal range. Am J Cardiol. 2010, 106 (11): 1602-5. 10.1016/j.amjcard.2010.07.036.CrossRefPubMed
19.
go back to reference Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL: Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J. 2006, 27 (11): 1341-81.CrossRefPubMed Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL: Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J. 2006, 27 (11): 1341-81.CrossRefPubMed
20.
go back to reference Kempf K, Füth R, Dinh W, Bansemir L, Köhler T, Bufe A, Scheffold T, Standl E, Martin S, Lankisch M: Screening for overt diabetes by oral glucose tolerance test: Stratification by fasting blood glucose and patients' age improve practicability of guidelines in cardiological routine. Int J Cardiol. 2010 Kempf K, Füth R, Dinh W, Bansemir L, Köhler T, Bufe A, Scheffold T, Standl E, Martin S, Lankisch M: Screening for overt diabetes by oral glucose tolerance test: Stratification by fasting blood glucose and patients' age improve practicability of guidelines in cardiological routine. Int J Cardiol. 2010
21.
go back to reference Knudsen EC, Seljeflot I, Michael A, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GØ: Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients. Cardiovasc Diabetol. 2009, 8: 6-10.1186/1475-2840-8-6.PubMedCentralCrossRefPubMed Knudsen EC, Seljeflot I, Michael A, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GØ: Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients. Cardiovasc Diabetol. 2009, 8: 6-10.1186/1475-2840-8-6.PubMedCentralCrossRefPubMed
22.
go back to reference Fujiwara R, Kutsumi Y, Hayashi T, Kim SS, Misawa T, Tada H, Nishio H, Toyota K, Tamai T, Nakai T: Metabolic risk factors in the normolipidemic male patients with angiographically defined coronary artery disease. Jpn Circ J. 1990, 54 (5): 493-500. 10.1253/jcj.54.493.CrossRefPubMed Fujiwara R, Kutsumi Y, Hayashi T, Kim SS, Misawa T, Tada H, Nishio H, Toyota K, Tamai T, Nakai T: Metabolic risk factors in the normolipidemic male patients with angiographically defined coronary artery disease. Jpn Circ J. 1990, 54 (5): 493-500. 10.1253/jcj.54.493.CrossRefPubMed
23.
go back to reference Horimoto M, Hasegawa A, Ozaki T, Takenaka T, Igarashi K, Inoue H: Independent predictors of the severity of angiographic coronary atherosclerosis: the lack of association between impaired glucose tolerance and stenosis severity. Atherosclerosis. 2005, 182 (1): 113-9. 10.1016/j.atherosclerosis.2005.01.037.CrossRefPubMed Horimoto M, Hasegawa A, Ozaki T, Takenaka T, Igarashi K, Inoue H: Independent predictors of the severity of angiographic coronary atherosclerosis: the lack of association between impaired glucose tolerance and stenosis severity. Atherosclerosis. 2005, 182 (1): 113-9. 10.1016/j.atherosclerosis.2005.01.037.CrossRefPubMed
24.
go back to reference Seibaek M, Sloth C, Vallebo L, Hansen T, Urhammer SA, Burchardt H, Torp-Pedersen C, Pedersen O, Hildebrandt P: Glucose tolerance status and severity of coronary artery disease in men referred to coronary arteriography. Am Heart J. 1997, 133 (6): 622-9. 10.1016/S0002-8703(97)70163-7.CrossRefPubMed Seibaek M, Sloth C, Vallebo L, Hansen T, Urhammer SA, Burchardt H, Torp-Pedersen C, Pedersen O, Hildebrandt P: Glucose tolerance status and severity of coronary artery disease in men referred to coronary arteriography. Am Heart J. 1997, 133 (6): 622-9. 10.1016/S0002-8703(97)70163-7.CrossRefPubMed
25.
go back to reference Takeda Y, Mifune J, Taga K, Hifumi S, Takahashi Y, Yamashita S, Murakami T, Tanaka T: Multiple risk factors in coronary artery disease patients with abnormal glucose tolerance. Jpn Heart J. 1991, 32 (1): 35-43. 10.1536/ihj.32.35.CrossRefPubMed Takeda Y, Mifune J, Taga K, Hifumi S, Takahashi Y, Yamashita S, Murakami T, Tanaka T: Multiple risk factors in coronary artery disease patients with abnormal glucose tolerance. Jpn Heart J. 1991, 32 (1): 35-43. 10.1536/ihj.32.35.CrossRefPubMed
26.
go back to reference Sourij H, Saely CH, Schmid F, Zweiker R, Marte T, Wascher TC, Drexel H: Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients. Eur Heart J. 2010 Sourij H, Saely CH, Schmid F, Zweiker R, Marte T, Wascher TC, Drexel H: Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients. Eur Heart J. 2010
Metadata
Title
A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels
Authors
Sven Schinner
Reiner Füth
Kerstin Kempf
Stephan Martin
Holger S Willenberg
Matthias Schott
Wilfried Dinh
Werner A Scherbaum
Mark Lankisch
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2011
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-10-56

Other articles of this Issue 1/2011

Cardiovascular Diabetology 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.